Identification of target genes within an amplicon at 14q12-q13 in esophageal squamous cell carcinoma
Version of Record online: 24 JUL 2001
Copyright © 2001 Wiley-Liss, Inc.
Genes, Chromosomes and Cancer
Volume 32, Issue 2, pages 112–118, October 2001
How to Cite
Yasui, K., Imoto, I., Fukuda, Y., Pimkhaokham, A., Yang, Z.-Q., Naruto, T., Shimada, Y., Nakamura, Y. and Inazawa, J. (2001), Identification of target genes within an amplicon at 14q12-q13 in esophageal squamous cell carcinoma. Genes Chromosom. Cancer, 32: 112–118. doi: 10.1002/gcc.1172
- Issue online: 29 AUG 2001
- Version of Record online: 24 JUL 2001
- Manuscript Accepted: 9 MAR 2001
- Manuscript Received: 16 JAN 2001
- Grant-in-Aid for Cancer Research from the Ministry of Education, Science, Sports and Culture
- Ministry of Health and Welfare and the Agency of Science and Technology
- Organization for Pharmaceutical Safety and Research (OPSR), Japan
Comparative genomic hybridization studies have revealed frequent amplification of the 14q12-q13 region in esophageal squamous cell carcinoma (ESC) cell lines. To identify genes targeted for amplification, we first defined the minimal common region of amplification using fluorescence in situ hybridization in affected ESC cell lines. The amplicon covered about 6 Mb, between markers D14S1034 and L18528. Then we screened 32 ESC cell lines to discern amplifications and expression levels of 26 expressed sequence tags (ESTs) that had been localized to the amplified region. Five known genes (BAZ1A, SRP54, NFKBIA, MBIP, and HNF3A) and two uncharacterized ESTs (GenBank Accession numbers AA991861 and AA167732) within the amplicon showed amplification and consequent overexpression. Two of these transcripts were amplified in three of the primary ESCs we examined. Our findings suggest that these seven genes are candidate targets of the amplification mechanism and therefore may be associated, together or separately, with development and progression of ESC. © 2001 Wiley-Liss, Inc.